Cargando…

1354. Reducing vancomycin utilization rate in a level 4 NICU

BACKGROUND: Vancomycin is frequently used empirically in suspected sepsis in neonatal intensive care unit (NICU). However, inappropriate or unnecessary use can lead to additional morbidities and emergence of drug resistant pathogens. Standardization of vancomycin use is imperative for safer and more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Millie R, Mongkolrattanothai, Kanokporn, Chin, Steven, Li, Yijie, Orbach, Regina, Stach, Leslie, Nair, Srikumar, Milisavljevic, Vladana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777588/ http://dx.doi.org/10.1093/ofid/ofaa439.1536

Ejemplares similares

276. Vancomycin Utilization in a Neonatal Intensive Care Unit
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2018)

519. Multidrug-resistant Gram-Negative Bacteremia in Pediatric Patients: Is It Time to Change to Empiric Meropenem?
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

477. Characterization of Extended-Spectrum Β-Lactamase (ESBL) Producing Gram-negative (GN) Urinary Tract Infections (UTI) in Pediatric Patients
por: Stach, Leslie, et al.
Publicado: (2019)

2122. Isavuconazonium for Invasive Fungal Therapy: Single-Center Pediatric Experience
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

2781. The Use of Aminoglycosides for Treatment of Urinary Tract Infections in Pediatric Patients, a Carbapenem-Sparing Approach
por: Legaspi, Jamie, et al.
Publicado: (2023)

Decreasing Vancomycin Utilization in the NICU by Optimizing Treatment Decisions in Suspected Late Onset Sepsis
por: Maffei, Diana, et al.
Publicado: (2017)

P1354: A SYSTEMATIC LITERATURE REVIEW (SLR) OF THE MANIFESTATIONS OF VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN ADULTS VERSUS CHILDREN
por: Angus, J., et al.
Publicado: (2022)

P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
por: Albinger, Nawid, et al.
Publicado: (2023)

1354. Novel Formulation SUBA-Itraconazole in Fed and Fasted Healthy Volunteers: Expanding the Clinical Utility of the Established Mold Active Agent
por: Lindsay, Julian, et al.
Publicado: (2018)

1354. Nocardia bejingensis: A Novel Isolate Affecting Immunocompromised Patients in the United States
por: Moore-Pardo, Shylah M, et al.
Publicado: (2019)

Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review
por: Chong, Jasmine, et al.
Publicado: (2016)

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
por: Naderi, Mandana, et al.
Publicado: (2020)

A Quality Improvement Initiative to Improve Perioperative Hypothermia Rates in the NICU Utilizing Checklists
por: Hanna, Morcos, et al.
Publicado: (2020)

Vein of Galen arteriovenous malformation with PAPVR and use of serial B-type natriuretic peptide levels in the management: a case report and review of the literature
por: Purdy, Isabell B, et al.
Publicado: (2010)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
por: Elhence, Hirsh, et al.
Publicado: (2022)

Vancomycin-resistant enterococci: eradication using vancomycin?
por: Van Prehn, J, et al.
Publicado: (2014)

1656. Evaluation of Using Oxacillin versus Vancomycin for Empiric Therapy of Late-Onset Neonatal Sepsis in NICU
por: Lien, Tsung-Chi, et al.
Publicado: (2023)

Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2009)

1328. Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children
por: Quraishi, Ruquaya, et al.
Publicado: (2020)

1354P Delay of diagnoses, increase of advanced stages, and worse overall survival in patients with thoracic malignancies because of the COVID-19 pandemic
por: Sbrana, A., et al.
Publicado: (2022)

1354. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of COVID-19: 15-Month Final Analysis of the PROVENT Phase 3 Study
por: Levin, Myron J, et al.
Publicado: (2023)

Comparison of Newborn Hearing Screening in Well-Baby Nursery and NICU: A Study Applied to Reduce Referral Rate in NICU
por: Li, Pei-Chun, et al.
Publicado: (2016)

1341. Blood Volume Collected for Blood Cultures in Infants with Suspected Neonatal Sepsis in the NICU
por: Altez, Maria S Rueda, et al.
Publicado: (2020)

78. Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Screen on Vancomycin Utilization for Respiratory Tract Infections
por: Debnath, Ashita, et al.
Publicado: (2021)

Evaluation of a Novel FKS1 R1354H Mutation Associated with Caspofungin Resistance in Candida auris Using the CRISPR-Cas9 System
por: Kiyohara, Maiko, et al.
Publicado: (2023)

A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China
por: Xie, Linjun, et al.
Publicado: (2023)

1119. Assessment of Vancomycin Pharmacokinetic Parameters in Pediatric Patients After Liver Transplantation
por: Morales, Ronaldo, et al.
Publicado: (2021)

Pharmacological errors in NICU
por: Foligno, Silvia, et al.
Publicado: (2014)

Concept of neuroprotective NICU
por: Gaffari, Mohammed, et al.
Publicado: (2019)

Setting the Ventilator in the NICU
por: Dargaville, Peter A., et al.
Publicado: (2013)

Impact of FilmArray™ Respiratory Panel testing on the clinical management of pediatric bone marrow transplant patients
por: Precit, Mimi R., et al.
Publicado: (2021)

Subcutaneous diclofenac at low dose is very effective in treating fever with an accompanying reduction in intracerebral pressure in NICU patients
por: Cormio, M, et al.
Publicado: (2004)

1108. Evaluation of Vancomycin Dosing in Adolescents
por: Weaver, Ashley I, et al.
Publicado: (2021)

P050: Containment of methicillin resistant staphylococcus aureus (MRSA) outbreak in a neonatal intensive care unit (NICU)
por: Eluk, O, et al.
Publicado: (2013)

102. Effects of an Antimicrobial Stewardship-guided MRSA Nasal Screening Review on Vancomycin Utilization for Respiratory Infections: A Quasi-Experimental Study
por: Pineda, Ross, et al.
Publicado: (2020)

87. Utilization of Methicillin-Sensitive/Resistant Staphylococcus aureus Nares Screen to Decrease Vancomycin and Linezolid Use in Hospitalized Patients with Respiratory Infections
por: Zaidan, Noor F, et al.
Publicado: (2020)

88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric
por: Hussain, Cory, et al.
Publicado: (2020)

Improving care collaboration for NICU patients to decrease length of stay and readmission rate
por: Welch, Cherrie D, et al.
Publicado: (2017)

Ionizing Radiation Exposure in NICU
por: Kartikeswar, G. A. P., et al.
Publicado: (2019)

Experience report on surveillance of vancomycin-resistant enterococci
por: Baraldi, MM, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cviuitq03okgldndrpevin0h5v